Neurotoxicity as a Mechanism for Neurodegenerative Disorders: Basic and Clinical Aspects

By Danysz W.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 985-989

Informa Healthcare

Access to resources Recommend Favorite

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

By  

Current Neuropharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 514-523

Bentham Science Publishers

Access to resources Recommend Favorite

Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action

By  

Current Pharmaceutical Design, Vol. 10, Iss. 22, 2004-08 ,pp. : 2719-2732

Bentham Science Publishers

Access to resources Recommend Favorite

The Hippocampus, Neurotrophic Factors and Depression: Possible Implications for the Pharmacotherapy of Depression

By Masi Gabriele   Brovedani Paola  

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 913-931

Adis International

Access to resources Recommend Favorite

GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-04 ,pp. : 127-140

Bentham Science Publishers

Access to resources Recommend Favorite